CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
5 Children’s Health Statistics Policymakers Need to Know
From coverage and funding to workforce and community support, every decision by policymakers has downstream effects on children, families, and the systems that care for them.
June 30, 2026
Energy and Commerce Health Subcommittee Hearing on Health Care Transparency
CHA is asking Congress to ensure policies provide clear cost information for families, reflect the unique nature of pediatric care, and avoid unnecessary administrative burden.
June 23, 2026
Site Neutral Policies Negatively Impact Children
Children’s hospitals extend pediatric care close to home for patients and families.
June 22, 2026
